Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Biochemistry

• Publication date

  1996-02-20

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI9520949PMID 8652577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of ligand-binding to the kringle 4 fragment from human plasminogen

  2004cited by this paper
• Ligand binding to the tissue-type plasminogen activator kringle 2 domain: structural characterization by 1H-NMR.

  1995cited by this paper
• Solution structure of the epsilon-aminohexanoic acid complex of human plasminogen kringle 1.

  1994cited by this paper
• Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator.

  1994cited by this paper
• Expression, purification and characterization of the recombinant kringle 2 and kringle 3 domains of human plasminogen and analysis of their binding affinity for omega-aminocarboxylic acids.

  1994cited by this paper
• Solution structure of the kringle domain from urokinase-type plasminogen activator.

  1994cited by this paper
• Kringle solution structures via NMR: two-dimensional 1H-NMR analysis of horse plasminogen kringle 4.

  1994cited by this paper
• Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin.

  1994cited by this paper
• The structure of recombinant plasminogen kringle 1 and the fibrin binding site

  1994cited by this paper
• Functional independence of the kringle 4 and kringle 5 regions of human plasminogen.

  1993cited by this paper
• 1H NMR characterization of the urokinase kringle module. Structural, but not functional, relatedness to homologous domains.

  1993cited by this paper
• Protein-ligand interactions in the lysine-binding site of plasminogen kringle 4 are different in crystal and solution. Electrostatic interactions studied by site-directed mutagenesis exclude Lys35 as an important acceptor in solution.

  1993cited by this paper
• Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution.

  1992cited by this paper
• Domain interactions in human plasminogen studied by proton NMR

  1991cited by this paper
• Direct analysis of the disulfide content of proteins: methods for monitoring the stability and refolding process of cystine-containing proteins.

  1991cited by this paper
• Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug.

  1991cited by this paper
• The refined structure of the epsilon-aminocaproic acid complex of human plasminogen kringle 4.

  1991cited by this paper
• Construction, expression, and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with omega-amino acids.

  1991cited by this paper
• Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-A resolution.

  1991cited by this paper
• Solution structure of the kringle 4 domain from human plasminogen by 1H nuclear magnetic resonance spectroscopy and distance geometry.

  1990cited by this paper
• Ligand interactions with the kringle 5 domain of plasminogen. A study by 1H NMR spectroscopy.

  1990cited by this paper
• 1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator.

  1989cited by this paper
• Reversible independent unfolding of the domains of urokinase monitored by 1H NMR.

  1989cited by this paper
• Purification and characterization of tissue plasminogen activator kringle-2 domain expressed in Escherichia coli.

  1989cited by this paper
• Lysine/fibrin binding sites of kringles modeled after the structure of kringle 1 of prothrombin

  1988cited by this paper
• Structure of prothrombin fragment 1 refined at 2.8 A resolution.

  1988cited by this paper
• Isolation, purification and 1H-NMR characterization of a kringle 5 domain fragment from human plasminogen.

  1987cited by this paper
• Proton magnetic resonance study of lysine-binding to the kringle 4 domain of human plasminogen. The structure of the binding site.

  1987cited by this paper
• Synthesis and sequence-specific proteolysis of hybrid proteins produced in Escherichia coli.

  1987cited by this paper
• Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: structure of the ligand-binding site.

  1987cited by this paper
• Proton magnetic resonance study of kringle 1 from human plasminogen. Insights into the domain structure.

  1986cited by this paper
• The aromatic 1H-NMR spectrum of plasminogen kringle 4. A comparative study of human, porcine and bovine homologs.

  1986cited by this paper
• Rapid analysis of amino acids using pre-column derivatization.

  1984cited by this paper
• High-sensitivity sequencing with a gas-phase sequenator.

  1983cited by this paper
• Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins.

  1983cited by this paper
• A 1H-NMR study of isolated domains from human plasminogen. Structural homology between kringles 1 and 4.

  1983cited by this paper
• Folding autonomy of the kringle 4 fragment of human plasminogen.

  1983cited by this paper
• The lysine binding sites of human plasminogen. Evidence for a critical tryptophan in the binding site of kringle 4.

  1981cited by this paper
• Studies on the lysine-binding sites of human plasminogen. The effect of ligand structure on the binding of lysine analogs to plasminogen.

  1980cited by this paper
• A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules.

  1980cited by this paper
• A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

  1979cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Construction and Properties of Escherichia coli Strains Exhibiting α-Complementation of β-Galactosidase Fragments In Vivo

  1972cited by this paper
• Plasminogen: Purification from Human Plasma by Affinity Chromatography

  1970cited by this paper

• Insights into the Giardia intestinalis enolase and human plasminogen interaction.

  2017cites this paper
• Analysis of plasminogen binding to Treponema denticola, a key periopathogen

  2013cites this paper
• Bacterial Plasminogen Receptors: Mediators of a Multifaceted Relationship

  2012cites this paper
• The plasmin–antiplasmin system: structural and functional aspects

  2011influential citation
• Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape.

  2010cites this paper
• Untersuchungen zur Struktur und Funktion der Plasminogen-bindenden alpha-Enolase aus Streptococcus pneumoniae und der Tubulin-Tyrosin Ligase aus Sus scrofa

  2004cites this paper
• Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.

  2003cites this paper
• Anti-angiogenic Activity of the Recombinant Kringle Domain of Urokinase and Its Specific Entry into Endothelial Cells*

  2003cites this paper
• Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator.

  2003cites this paper
• TUMOR VASCULATURE AS A TARGET

  2002cites this paper
• The Col-1 Module of Human Matrix Metalloproteinase-2 (MMP-2): Structural/Functional Relatedness between Gelatin-Binding Fibronectin Type II Modules and Lysine-Binding Kringle Domains

  2002cites this paper
• The two-domain NK1 fragment of plasminogen: folding, ligand binding, and thermal stability profile.

  2002cites this paper
• Adenosine 5′-Phosphosulfate Sulfotransferase and Adenosine 5′-Phosphosulfate Reductase Are Identical Enzymes*

  2000cites this paper
• Tetranectin-binding site on plasminogen kringle 4 involves the lysine-binding pocket and at least one additional amino acid residue.

  2000cites this paper
• Mutational Analysis of Affinity and Selectivity of Kringle-Tetranectin Interaction

  2000cites this paper
• Expression, isolation and characterization of a mutated human plasminogen kringle 3 with a functional lysine binding site

  1999cites this paper
• Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains.

  1999cites this paper
• Structural/functional properties of the Glu1‐HSer57 N‐terminal fragment of human plasminogen: Conformational characterization and interaction with kringle domains

  1998cites this paper
• Lysine‐50 is a likely site for anchoring the plasminogen N‐terminal peptide to lysine‐binding kringles

  1998cites this paper
• Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis

  1998cites this paper
• Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.

  1997cites this paper
• Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli.

  1997cites this paper
• Kringle Domains of Human Angiostatin

  1996cites this paper